LONG-TERM SAFETY OF TICAGRELOR MONOTHERAPY IN PATIENTS UNDERGOING PCI FOR STABLE CORONARY ARTERY DISEASE IN THE GLOBAL LEADERS STUDY: IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Mariusz Tomaniak,Ply Chichareon,Kuniaki Takahashi,Norihiro Kogame,Rodrigo Modolo,Chun Chin Chang,Yuki Katagiri,Ernest Spitzer Cano,Franz-Joseph Neumann,Sylvain Plante,Rosana Hernandez Antolin,Valeri Gelev,Philippe Brunel,Farzin Beygui,Krzysztof Filipiak,Robert J. van Geuns,Christian Hamm,Robert F. Storey,Osama Ibrahim Ibrahim Soliman,Yoshinobu Onuma,Pascal Vranckx,Stephan Windecker,Marco Valgimigli,Patrick W. Serruys

LONG-TERM SAFETY OF TICAGRELOR MONOTHERAPY IN PATIENTS UNDERGOING PCI FOR STABLE CORONARY ARTERY DISEASE IN THE GLOBAL LEADERS STUDY: IMPACT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

2019

Data on long-term safety and efficacy of ticagrelor in patients with stable coronary artery disease (CAD) and chronic obstructive pulmonary disease (COPD) undergoing percutaneous coronary intervention (PCI) are limited. This is a post-hoc analysis of the safety and efficacy of ticagrelor among

Keywords:

Percutaneous coronary intervention
Coronary artery disease
Disease
Conventional PCI
Diabetes mellitus
Cardiology
Ticagrelor
Medicine
COPD
Internal medicine
in patient
pulmonary disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations